METLY
Metly is an artificial intelligence platform for business development teams in the pharmaceutical industry. It helps identify new licensing and manufacturing opportunities, assess their strategic fit, and connect directly with the right partners.
METLY
Metly is an artificial intelligence platform for business development teams in the pharmaceutical industry. It helps identify new licensing and manufacturing opportunities, assess their strategic fit, and connect directly with the right partners.
TL;DR
What they do: AI intelligence platform for pharmaceutical business development (identify licensing, manufacturing, partnership opportunities)
Headquarters: Barcelona, Catalonia, Spain
Founded: 2024
Recent funding: Pre-seed / Seed round closed Jul 2025 (~€520k / $780k reported)
Founders: Anna Saldo; Lydia Taranilla
Company Overview
Problem Domain
Business development and partner discovery for pharmaceutical companies
Founded
2024
Industry
Pharmaceuticals; SaaS / AI
Funding Track Record
~€520,000
Investors named in reporting include Ona Capital (Ona Capital Privat SCR SA), Encomenda Capital Partners, Dozen Investments and angel investors; reported proceeds vary across sources.
Investor Signal
“Investors include Ona Capital, Encomenda Capital Partners, Dozen Investments and individual angel investors”